We are studying whether Eculizumab can improve kidney function in patients with a severe kidney condition linked to high blood pressure. This trial will help us understand its effects on dialysis needs and overall health.
Health conditions and diseases that the clinical trial is designed to study and treat.
Atypical Hemolytic Uremic Syndrome (aHUS) is a rare condition characterized by the destruction of red blood cells, low platelet count, and kidney failure, often requiring dialysis. It can lead to severe complications if not treated promptly.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.